On March 2024, our CTO, Dr Elita Montanari, was awarded the best short talk presentation at Controlled Release Society German Local Chapter 2024.
Elita presented our novel technology for nucleic acid loading of extracellular vesicles.
📅 21–22 October 2025📍 Palazzo Benevenuti, Trento, Italy EVis Bioscience was proud to attend the Immagina RNA Symposium 2025 – “From Translatome to Targeted Therapies”, held in Trento and organized by Immagina Biotechnology. The event gathered leading experts in RNA biology and translational medicine, highlighting the latest advances in RNA-based therapeutic technologies. 👉 Read more…
Evis Bioscience was proud to attend the ISEV2025 Annual Meeting, held in Vienna from 24 to 27 April 2025. The event was a valuable opportunity to connect with the global extracellular vesicle community and to present our latest advancements in hybrid delivery technologies for nucleic acid therapeutics. Thank you to everyone who visited our team!…
🧬 Find more on our new technology here: Hybridization of extracellular vesicles with lipid nanovectors